Compass Therapeutics Inc.
CMPX
Closed
$2.38
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Boston, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2020-11-13.
Country
US
CEO
Dr. Thomas Schuetz
IPO date
2020
Employees
39
ISIN
US20454B1044
Website
Key stats
Open
$2.36
Volume
1.92M
Market cap
$425.01M
Prev. close
$2.36
Impl / hst vl
-
Open interest
$0.00
$2.34
Day’s Range
$2.45
$1.61
52W Range
$6.88
Valuation
27
Valuation score
Overvalued
P/E
-
P/S
-
P/B
2.45
Current ratio
11.22
Debt / Equity
-0.21
ROE
-
Gross margin
-
Income growth
-
FCF growth
-14.05
Analysts estimates
Consensus rating
Buy
The average rating from top 10 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$8.67
The top 14 analysts forecasts that 12-month price may increase by 264.29%, with a low of $4.04 and a high of $25.20
$4.04
Low
$8.67
Avg
$25.20
High
Current price
Earnings
Q4 ‘25 revenue
$0.00
Q4 ‘25 net income
-$15.72M
Revenue
Net income
Previous EPS
-$0.10
Estimate EPS
-$0.11
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply